Dysphagia and Muscle Weakness Secondary to Botulinum Toxin Type A Treatment of Cervical Dystonia: A Drug Class Analysis of Prescribing Information

  • Khashayar Dashtipour
  • , Han S. Lee
  • , Aaron Ellenbogen
  • , Rashid Kazerooni
  • , Todd M. Gross
  • , David A. Hollander
  • , Conor J. Gallagher

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article number442
JournalToxins
Volume16
Issue number10
DOIs
StatePublished - Oct 2024

ASJC Scopus Subject Areas

  • Toxicology
  • Health, Toxicology and Mutagenesis

Keywords

  • botulinum toxins
  • cervical dystonia
  • dysphagia
  • dystonic disorders
  • movement disorders
  • muscle weakness
  • neuromodulator
  • peptides
  • type A

Cite this